AllianceBernstein’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

AllianceBernstein’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-781,565	Closed	-$14.6M	–	3468
2022 Q1	$14.6M	Buy	781,565 +633,196	+427%	+$11.4M	0.01%	1053
2021 Q4	$3.17M	Sell	148,369 -49,270	-25%	-$971K	﹤0.01%	1866
2021 Q3	$3.65M	Buy	197,639 +32,433	+20%	+$653K	﹤0.01%	1778
2021 Q2	$3.54M	Buy	165,206 +66,867	+68%	+$1.36M	﹤0.01%	1836
2021 Q1	$1.9M	Buy	+98,339	New	+$1.73M	﹤0.01%	2137

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AllianceBernstein's OCDX Position: Q2 2022 in Review

AllianceBernstein sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 781,565 shares — an estimated $14.6M sold.

AllianceBernstein first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $14.6M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

AllianceBernstein reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
AllianceBernstein sold 781,565 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $14.6M.
AllianceBernstein first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
AllianceBernstein's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $14.6M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.